Zinc levels and diabetic kidney disease severity
Part of Hormones & metabolism, Kidney & urinary clinical trials.
This study looks at whether zinc levels in the blood are linked to how severe diabetic kidney disease is. It could help doctors better understand and manage kidney problems in people with diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with diabetic kidney disease.
- You are not currently on dialysis.
- You do not have other kidney diseases like lupus nephritis or glomerulonephritis.
- You are willing to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial focuses on improving how kidney damage is diagnosed and how treatment is planned for people with type 2 diabetes and kidney disease. It may help by using detailed medical history and (if done) kidney biopsy results to guide care more accurately.
This study checks if zinc levels in the blood are linked to lupus nephritis. It may help doctors understand how zinc affects kidney health in people with lupus.
This trial checks if the balance of copper and zinc in your blood affects health outcomes for people with end-stage kidney disease on dialysis. It does not test a new drug, but may help doctors understand your condition better.
This study looks at how the bacteria in your gut and certain substances in your blood might affect blood sugar changes and kidney health in people with diabetic kidney disease. If you have type 2 diabetes and kidney issues, this trial could help find better ways to track your condition.
This study looks at people with type 2 diabetes who have kidney problems and relates their symptoms and lab findings to what is seen on kidney biopsy. It may help doctors better understand what is driving kidney damage in diabetes.
This study tests whether taking zinc can improve how your body controls blood sugar in people with prediabetes. It may help slow the progression toward type 2 diabetes, but you would need to meet specific health and medication criteria.
Hear when a new Diabetic Nephropathy Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.